H Ogino
-
- Cancer-related Molecular Pathways 4
-
- Microtubule and mitosis dynamics 1
-
- Ubiquitin and proteasome pathways 1
-
- Blood properties and coagulation 1
-
- Liver Diseases and Immunity 1
-
- COVID-19 Clinical Research Studies 1
-
- Venous Thromboembolism Diagnosis and Management 1
-
- Chemotherapy-related skin toxicity 1
- Co-authors
- Yoichi TayaHideaki HigashiHisanori MatsumotoIkuko Suzuki‐TakahashiMasatoshi KitagawaTakayoshi OkabeHideyo YasudaAyako Okuyama
- Cited by
- OncologyCell BiologyBiotechnology
- Journals
- CHEST Journal (1 paper)Respiration (2 papers)PubMed (4 papers)
- Partner nations
- Japan
In The Last Decade
H Ogino
7 papers receiving 355 citations
Peers
Comparison fields: 5 of 58
- Oncology 186
- Cell Biology 101
- Biotechnology 32
- Reproductive Medicine 29
- Molecular Biology 234
Countries citing papers authored by H Ogino
This map shows the geographic impact of H Ogino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Ogino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Ogino more than expected).
Fields of papers citing papers by H Ogino
This network shows the impact of papers produced by H Ogino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Ogino. The network helps show where H Ogino may publish in the future.
Co-authorship network
The 25 scholars most cited alongside H Ogino, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The interactions of E2F with pRB and with p107 are regulated via the phosphorylation of pRB and p107 by a cyclin-dependent kinase. | 1995 | 39 |
| 2 | 1994 | 1 | |
| 3 | A cyclin-dependent kinase inhibitor, butyrolactone I, inhibits phosphorylation of RB protein and cell cycle progression. | 1994 | 103 |
| 4 | Butyrolactone I, a selective inhibitor of cdk2 and cdc2 kinase. | 1993 | 192 |
| 5 | 1992 | 2 | |
| 6 | cdc2-like kinase is associated with the retinoblastoma protein. | 1992 | 25 |
| 7 | 1991 | 8 |
About H Ogino
H Ogino is a scholar working on Internal Medicine, Oncology and Hepatology, having authored 7 papers that have together received 370 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (4 papers), Blood properties and coagulation (1 paper), Liver Diseases and Immunity (1 paper), COVID-19 Clinical Research Studies (1 paper), Microtubule and mitosis dynamics (1 paper), Ubiquitin and proteasome pathways (1 paper), Venous Thromboembolism Diagnosis and Management (1 paper) and Chemotherapy-related skin toxicity (1 paper). The work is most often cited by research in Oncology (186 citations), Cell Biology (101 citations) and Biotechnology (32 citations). H Ogino has collaborated with scholars based in Japan. Frequent co-authors include Yoichi Taya, Hideaki Higashi, Hisanori Matsumoto, Ikuko Suzuki‐Takahashi, Masatoshi Kitagawa, Takayoshi Okabe, Hideyo Yasuda, Ayako Okuyama, Masanobu Kitagawa and Taijiro Okabe. Their work appears in journals such as CHEST Journal, Respiration and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.